Daré Bioscience gets Nasdaq notice after shares trade below $1 minimum bid price
DARE•Daré Bioscience received a Nasdaq notice after its shares traded below the $1.00 minimum bid price for 30 consecutive business days. It has until March 29, 2027, to regain compliance while remaining listed.
1. Compliance window
Nasdaq gave Daré Bioscience 180 days, through March 29, 2027, to comply with its minimum bid price rule. Compliance requires a closing bid of at least $1.00 for 10 consecutive business days. If the company does not regain compliance by the deadline, it could receive a delisting notice; a reverse stock split is among potential ways to address the deficiency.
